Sunrise Group secures FDA clearance for home sleep test
May 20, 2026
The lightweight, at-home sensor records MJM, a validated biosignal for sleep evaluation.
The lightweight, at-home sensor records MJM, a validated biosignal for sleep evaluation.
According to Guardant, Guardant360 Liquid assesses a ‘100x wider’ genomic footprint to guide cancer treatment decisioning than its predecessor.
Sentante announced today that it received CE mark for its flagship endovascular surgical robot platform for treating stroke.
SYDNEY, May 18, 2026 /PRNewswire/ — SeeTreat’s ART.1-US software delivering automated adaptive decision support for every patient at every treatment is cleared for use in the USA. From today, US clinics with Varian or Elekta CT linear accelerators, will be able to access daily evaluations of radiotherapy dose to patients’ changing anatomy. With ART.1-US, clinical teams can now decide the right time for a new radiotherapy plan in 95+ seconds[1], and download supporting clinical documentation.
Galvanize Therapeutics announced today that it received FDA clearance for its Aliya EX generator for the surgical ablation of soft tissue.
Ideating on Glooko’s existing EndoTool system, the cloud-based version is designed to support more scalable deployment across hospital settings.
The assay enables ChLIA measurement of testosterone markers, delivering diagnostic capabilities for suspected male hypogonadism.
SonoMotion announced today that the company picked up updated FDA clearance for its Break Wave lithotripsy platform.
IVDR-compliant PCR test supports detection of 11 clinically relevant gastrointestinal pathogens from 1 sample
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.